Editorial Policies

Focus and Scope

Journal of Rare Cardiovascular Diseases (JRCD) is an international, quarterly issued, peer-reviewed, open access, online journal that keeps cardiologists and non-cardiologists up-to-date with rare disorders of the heart and vessels.
The Journal publishes fine quality review articles, original, basic and clinical sciences research papers, either positive or negative, case reports and articles on public health issues in the field of rare cardiovascular diseases and orphan cardiovascular drugs.
Topics of interest include, but are not limited to the following areas:

(1) rare diseases of systemic circulation
(2) rare diseases of pulmonary circulation
(3) rare diseases of the heart (cardiomyopathies)
(4) rare congenital cardiovascular diseases
(5) rare arrhythmogenic disorders
(6) cardiac tumors and cardiovascular diseases in malignancy
(7) cardiovascular diseases in pregnancy
(8) basic science
(9) quality of life

 Journal of Rare Cardiovascular Diseases follows the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals. JRCD respects publication ethics as set out by the Committee on Publication Ethics (COPE).
Submission of a manuscript to the Journal of Rare Cardiovascular Diseases implies that all authors have read and agreed to its content and that the manuscript conforms to the journal’s policies.
JRCD accepts submissions from all international regions.

 

Section Policies

Introduction / Editorial

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Original Article

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Case Report

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Reports

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Review papers / Guidelines / Classifications

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

All submissions to the Journal are initially reviewed by editor and section editors. At this stage manuscripts may be rejected without peer review, if they fail to meet submission requirements or are otherwise inappropriate. Some manuscripts may be returned to authors for revision and resubmission prior to peer review process.

Submissions, that are not rejected at the first stage, are sent for peer review by at least two appropriate, independent referees. A blinded peer review process is conducted, in which the reviewers' names are routinely withheld from the author unless a reviewer requests a preference for his or her identity to be revealed.

Selection of peer-reviewers is based upon the expertise of potential referees in the field to which the manuscript refers. Responsibility for choosing appropriate reviewers rests on an editor.

Authors, if they wish, may suggest potential referees to their work, however, whether or not to consider these reviewers is at the editor's discretion. Authors should not suggest recent collaborators or colleagues who work in the same institution as themselves. Authors who wish to suggest peer reviewers can do so by adding their salutation, name and surname, affiliation and email address to the title page under a caption ‘Suggested referees’.

Editors will make a decision on the manuscript relying on the reviewers’ evaluation reports and their own appraisal. These reports, along with the editorial decision will be sent to the authors. Possible decisions are:

- Accept Submission

- Revision Required, inviting the authors to revise their manuscript to address specific concerns outlined by reviewers and editor before a final decision is reached.

- Decline Submission, typically on grounds of major conceptual flaws or gross technical and/or interpretational problems.

All manuscripts are reviewed as rapidly as possible and editorial decision is announced without undue delay.

Any manuscript submitted to the Journal is a confidential document and should remain so until it is formally published.

 

Publication Frequency

Publication Frequency

This Journal is published quarterly. A new issue is released in March, June, September and December each year and is added to current volume. Each volume consists of 8 issues. Page numbering is conducted continuously for each volume.

 

Open Access Policy

Journal of Rare Cardiovascular Diseasesis an Open Access Journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author (according to Publisher’s license).
This is in accordance with the Budapest Open Access Initiative (BOAI) definition of Open Access.

 

Additional informations

Article Processing Charges

Journal of Rare Cardiovascular Diseases neither SoftQ sp. z o.o. does not collect any article processing charges from author(s) or authors' sponsors for any type of article. This means that publication process including peer-reviewing, editing, publishing, maintaining and archiving is conducted free of charge for author(s) or authors' sponsors. Open access format of the Journal allows the scientific community and the general public to have, for free, unlimited and immediate access to all content of the journal as soon as it is published on the Internet.

Publication Ethics

All research must have been carried out within an appropriate ethical framework.

Plagiarism, duplicate submission, data fabrication or falsification are serious acts of misconduct. When scientific misconduct is alleged, or concerns are otherwise raised about the conduct or integrity of work described in submitted or published papers, appropriate procedures detailed by the Committee on Publication Ethics (COPE) will be initiated.

Material (such as illustrations) taken from other publications must be accompanied by the publisher’s permission with a notice ‘Reproduced with permission of …’.

Statement on Human Rights

Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption). Further information and documentation to support this should be made available to the Editor on request.

Statement of Informed Consent

For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript.

Statement of Informed Consent for publication of individual patient data

For all manuscripts that include details, images, videos or other identifying characteristics relating to individual participants, written informed consent for the publication of these should be obtained from the participants (or their parent or legal guardian in the case of children under 16) and a statement to this effect should appear in the manuscript. In cases where images or other materials containing participant’s characteristics are entirely unidentifiable and there are no details on individuals reported within the manuscript, consent for publication of these materials may not be required. The final decision on whether consent to publish is required lies with the Editor.

Statement on Animal Rights

Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declaration outlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.

A statement detailing compliance with relevant guidelines (e.g. the Directive 2010/63/EU) and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption and the reasons for the exemption).

Authorship

We advise to follow the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals in identifying authors of the manuscript. To qualify as an author one should have (all 4 required):

1. made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;

2. been involved in drafting the manuscript or revising it critically for important intellectual content;

3. given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content;

4. agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All contributors who do not meet the criteria for authorship should be listed in an ‘Acknowledgements’ section.

Standards of Reporting

Journal of Rare Cardiovascular Diseases advocates complete and transparent reporting of biomedical and biological research. Authors are recommended to adhere to the EQUATOR Network when preparing their manuscript

Availability of data and materials

Submission of a manuscript to the Journal of the Rare Cardiovascular Diseases implies that materials described in the manuscript, including all relevant raw data, will be freely available to any scientist wishing to use them for non-commercial purposes, without breaching participant confidentiality.

Corrections and retractions

If correction or retraction of article(s) published in this Journal are necessary, the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and the Committee on Publication Ethics (COPE) guidelines will be implemented.

 

Conflict of Interest

All participants in the peer-review and publication process—not only authors but also peer reviewers, editors, and editorial board members of journals—must consider their conflicts of interest when fulfilling their roles in the process of article review and publication and must disclose all relationships that could be viewed as potential conflicts of interest.

Authors: When they submit a manuscript they are responsible for disclosing all financial and personal relationships that might bias or be seen to bias their work. The ICMJE has developed a Form for Disclosure of Conflicts of Interest to facilitate and standardize authors’ disclosures. If there is no potential conflict of interest, please include on the title page a notice ‘Conflict of interest: none declared’.

Reviewers: Reviewers are asked at the time they are invited to critique a manuscript if they have conflicts of interest, that could complicate their review. Reviewers must disclose to editors any conflicts of interest that could bias their opinions of the manuscript, and should recuse themselves from reviewing specific manuscripts if the potential for bias exists. Reviewers must not use knowledge of the work they’re reviewing before its publication to further their own interests.

Editors and Journal Staff: Editors who make final decisions about manuscripts or other editorial staff members who participate in editorial decisions should recuse themselves from proceeding if they have conflicts of interest or relationships that pose potential conflicts related to articles under consideration. Editorial staff must not use information gained through working with manuscripts for private gain. Guest editors should follow these same procedures.

Reporting Conflicts of Interest: Manuscripts are published with an appropriate notice whether there is not or is a conflict of interest detailing its type and character. All sources of funding should be acknowledged in the manuscript.

 

Disclaimer

The authors, editors and publisher will not accept any legal responsibility for any errors or omissions that may be made in this publication.

The publisher makes no warranty, express or implied, with respect to the material contained herein.

The authors implicitly agree to their paper being peer-reviewed. All manuscripts will be reviewed by Editorial Board members who reserve the right to reject or accept the manuscript without entering the review process in the case that the topic, the format or ethical aspects are inappropriate or represent undisputable quality. Once accepted, all manuscripts are subjected to copy editing.

For further information about editorial policies or publication terms please contact the Editorial Office of the Journal of Rare Cardiovascular Diseases, Centre for Rare Cardiovascular Diseases, John Paul II Hospital in Kraków; 80 Prądnicka Str., 31-202 Kraków, Poland; Phone: +48 (12) 614 33 99, +48 (12) 614 34 88 Fax: +48 (12) 614 34 88; e-mail: rarediseases@szpitaljp2.krakow.pl; jrcd@jrcd.eu or the Publisher SoftQ sp. z o.o., 2 Oleandry str., 30-063 Kraków, Poland; Phone: +48 (12) 444 1650; Fax: +48 (12) 444 1659; e-mail: softq@softq.pl

 

Advertising Policy

Advertisements may be accepted for publication if the Journal of Rare Cardiovascular Diseases. For more information please contact the Editorial Office of the Journal of Rare Cardiovascular Diseases, Centre for Rare Cardiovascular Diseases, John Paul II Hospital in Kraków; 80 Prądnicka Str., 31-202 Kraków, Poland; Phone: +48 (12) 614 33 99, +48 (12) 614 34 88 Fax: +48 (12) 614 34 88; e-mail: rarediseases@szpitaljp2.krakow.pl; jrcd@jrcd.eu or the Publisher SoftQ sp. z o.o., 2 Oleandry str., 30-063 Kraków, Poland; Phone: +48 (12) 444 1650; Fax: +48 (12) 444 1659; e-mail: softq@softq.pl

 

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

 

Abstracting/indexing

Journal of Rare Cardiovascular Diseases is abstracted/indexed in following databases:

Journal of Rare Cardiovascular Diseases (JRCD)
Centre for Rare Cardiovascular Diseases, John Paul II Hospital in Kraków,
80 Prądnicka Str., 31-202 Kraków, Poland
Phone: +48 (12) 614 33 99, +48 (12) 614 34 88 Fax: +48 (12) 614 34 88
e-mail: rarediseases@szpitaljp2.krakow.pl
Published on behalf of Fundacja Dla Serca w Krakowie by:
SoftQ sp. z o.o. ul. Oleandry 2, 30-063 Kraków, Poland
Phone: +48 (12) 444 1650 Fax: +48 (12) 444 1659
e-mail: softq@softq.pl

Copyright © 2015 Journal of Rare Cardiovascular Diseases; Fundacja Dla Serca w Krakowie